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Introduction
Curative plasmapheresis is a method of related therapy 
applied in different pathological conditions in order to remove 
from the body pathological products of different genesis 
[1]. The mechanism of elimination and biotransformation 
of the pathological substrate is the key to the detoxification 
effect. The correction of the rheological status is achieved 
by the mechanism of decreasing blood viscosity, increasing 
plasticity and decreasing the aggregation of blood cells [2]. 
Immunocorrection is due to the elimination of immune 
complexes, cytokines, immunocompetent cells thus 
achieving the “unblocking” of the immune system [3]. In the 
intensive care unit, the technique of curative plasmapheresis 
is widely applied among severe patients, who show signs of 
both endogenous and exogenous intoxication [4].
COVID-19 is a systemic pathology with a significant 
impact on the hematopoietic system and the immune 
system [6, 8, 9, 14]. Lymphopenia can be considered a 
laboratory indicator of major significance for the prognosis 
of COVID-19 patients with the evaluation of serum ferritin. 
The neutrophil / lymphocyte ratio and the maximum 
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Abstract
Background: In the intensive care unit, the curative plasmapheresis technique is widely applied among severe patients, who show signs of both endogenous 
and exogenous intoxication. The impact of isovolemic isooncotic curative plasmapheresis on the status of hemoleukogram and immunological markers 
has not been studied yet.
Material and methods: The study is retrospective, observational. The medical records of 34 COVID-19 patients from the COVID intensive care units 
of Timofei Mosneaga Republican Clinical Hospital who benefited from isovolemic, curative isooncotic plasmapheresis were analyzed. There were 25 
complete, analyzed data sets. General data were recorded: preplasmapheresis, postplasmaphesis hemoleukogram. 
Results: Isovolemic, isooncotic plasmapheresis, performed in patients with severe COVID-19, SARS-CoV2 showed effects of improving the status of 
laboratory indices that denote the evolution and favorable prognosis of the disease. The activity of the cytokine storm decreased in both groups of patients, 
both in those with a mean age of up to 60 years and in those over 60 years of age, with p = 0.001. Patients over 60 years of age had a marked improvement 
in serum ferritin index, compared to patients in the age group up to 60 years, in the period after plasmapheresis, p = 0.043. Analogously, the level of 
C-reactive protein was analyzed, which clearly decreases in patients <60 years of age, compared to those> 60 years of age, p = 0.037
Conclusions: Isovolemic, isooncotic plasmapheresis is a procedure performed in severe COVID-19 (SARS-CoV-2) patients to improve the status of 
the cytokine storm. Moreover, the performance of the procedure in different age groups induced an improvement in the satiety of hemoleukogram and 
proinflammatory indices.
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platelet / lymphocyte ratio may also have prognostic value 
in determining severe cases [3].
Some authors recommend close monitoring of leukocyte 
count, lymphocyte count, platelet count, and serum ferritin 
as markers for determining the potential prognosis for a 
critical disease [12, 13].
No references were found to the impact of plasmapheresis 
on the status of the hemoleukogram and the cytokine storm 
in COVID-19 (SARS-CoV-2) patients in the intensive care 
unit. In this regard, the aim of the study was to evaluate the 
status of hemoleukogram and proinflammatory markers in 
severe patients in the Intensive Care Unit with the diagnosis 
of COVID-19 [7, 10 11].
Material and methods
The study is retrospective, observational. The medical 
records of 34 COVID-19 patients from the COVID intensive 
care units of Timofei Mosneaga Republican Clinical Hospital 
who benefited from isovolemic, curative isooncotic 
plasmapheresis were analyzed. Duration of data collection: 
April-May 2020. The participants eligible to be included 
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in the study were 34 patients. There were 25 patients with 
complete data sets containing fully analyzed data sheets.
The indications for the plasmapheresis procedure 
were: elevated values of serum ferritin, C-reactive protein, 
lymphocytopenia.
The inclusion criteria in the study were:
•	 Adult patient (≥18 years), beneficiary of curative plas-
mapheresis;
•	 Patient diagnosed with COVID-19 in intensive care.
The exclusion criteria from the study were:
•	Incomplete	standardized	data	sheet.
Statistical analysis
The numerical values of the parameters were numbered 
in the Excel table, after which – imported into the statistical 
analysis software GraphPad Prism version 8. The data 
are presented in the form of absolute and relative values, 
or average and interval 95% reliable average. Applied 
statistical tests: One way ANOVA, Simple T test. P <0.05 
was considered statistically significant.
Results
The dynamics of the laboratory parameters, measured 
before and after the plasmapheresis session is presented in 
table 1.
Analysis of hemoleukogram data and proinflammatory 
markers up to plasmapheresis vs the period after plasma-
pheresis, in patients up to 60 years of age and over 60 years, 
shows in both age groups a positive dynamics of the results 
of laboratory indices. Of note is the result for serum ferritin, 
which in the general group shows a significant decrease in 
mean values with n = 1093.7 to n = 564.1.
The results shown in table 1 demonstrate an improve-
ment in immune status, with an increase in the number of 
lymphocytes in the whole group from 7% to 12.69% and in 
age groups from 9% to 15% (over 60 years), from 6% to 11% 
(under 60 years).
Discussion 
The activity of the cytokine storm decreased in both 
groups of patients: with an average age of up to 60 years and 
in over 60 years of age.
In the series of data with values  of laboratory parameters, 
it was observed that in some patients the results of the 
analyses decreased faster, and in others – slower. Thus, the 
results were analyzed in patients depending on the presence 
of comorbidities, which according to the literature influence 
the severity prognosis of COVID-19, SARS-CoV2.
Bolagholi S. et al. [4] noticed that plasmapheresis has a 
beneficial impact on prognosis of COVID-19, but there is 
no evidence about the influence of the comorbidities on the 
dynamics of the process.
 Patients in the study who had concomitant diabetes 
mellitus, the outcome of hemoleukogram indices and 
proinflammatory markers were evaluated to determine 
the influence of concomitant pathology on plasmapheresis 
efficacy. Blood glucose values  were not investigated in the 
patients included in the study. The patient with diabetes 
mellitus was evaluated as a criterion.
The number of leukocytes, C-reactive protein, serum 
ferritin, and lymphocytes in patients with diabetes mellitus 
after isovolemic isooncotic plasmapheresis, while maintain-
ing hemodynamic and respiratory protective status, were 
evaluated and the result showed an improvement in this 
proinflammatory status of patients after plasmapheresis.
Table 1. Dynamics of laboratory parameters before and after isovolemic isooncotic plasmapheresis 
Parameter Preplasmapheresis Postplasmapheresis t p
(n=) (N=)
PCR (whole batch) mg/dl 118.91 55.3 2.11 0.0001
PCR sublot over 60 years 135.71 38.13 1.451 0.0011
PCR sublot under 60 years 108.41 66.04 2.34 0.005
Leukocytes (whole group) 13.86 13.16 3.4 0.0001
Leukocytes sublot over 60 years 11.49 13.02 3.43 0.0005
Leukocytes sublot under 60 years 15.34 13.26 3.91 0.0017
Lymph (whole group) 7% 12.69% 1.41 0.0001
Lymph sublot over 60 years 9% 15% 1.29 0.001
Lymph sublot under 60 years 6% 11% 1.52 0.0003
Monocytes (whole lot) 4.08 3.25 1.61 0.0001
Monocytes sublot over 60 years 3.42 3.2 1.84 0.0467
Monocytes sublot under 60 years 4.08 3.2 1.65 0.0002
Ferritin (whole lot) 1093.73 765.35 2.35 0.0001
Ferritin it sublot over 60 years 613.08 564.1 2.27 0.04
Ferritin sublot under 60 years 1394.15 891.13 2.498 0.0005
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Similarly, the patients in the study who had concomitant 
hypertension were analyzed from a statistical point of 
view, which according to previous research is also a 
reserved prognostic indicator in case of severe evolution of 
COVID-19.
During the research, the results of hemoleukogram 
indices and proinflammatory markers were analyzed in 
patients with concomitant hypertension for determining 
the degree of influence of the concomitant condition on 
the efficacy of plasmapheresis. The T-student test presented 
a statistically significant result with p = 0.045, with the 
improvement of the laboratory indicators analyzed among 
patients with hypertension, although the evolution of 
the dynamics of laboratory analyses is noticeable to be 
slow. Similar to the group of patients with diabetes, no 
different blood pressure values  were analyzed, and the 
results of the indices after performing the plasmapheresis 
procedure. Reference value showed the presence or 
absence of pathology of hypertension in the patient. There 
was a positive evolution of proinflammatory markers and 
hemoleukogram in this group of patients, significant both 
clinically and statistically.
In the research, similar to other subjects, it was 
determined that the age of over 60 increases the predictability 
of mortality and morbidity for COVID-19. As reference 
markers of the cytokine storm in the study, the following 
were selected: C-reactive protein, serum ferritin and 
lymphocytes. Thus, one of the objectives was to analyze the 
correlation of different age groups with the evolution of the 
above-mentioned indices at the stage of pre-plasmapheresis 
and post-plasmapheresis for establishing the existence of 
the correlation between the plasmapheresis procedure and 
the results of the laboratory indices.
Rodríguez-Morales A., Cardona-Ospina J. et al. [5] 
in their meta-analyses determined that the impact of 
comorbidities on the prognostic of the COVID-19, in ICU 
patients is huge, and the damage as well. This study brings 
the high-light of a procedure that may improve the outcome 
in that group of patients. More studies are needed to be 
continued for better analyses. 
Thus, four groups of patients were statistically analyzed. 
The indicator analyzed was the value of C-reactive protein. 
There is a decrease in C-reactive protein levels in post-
plasmapheresis patients, both in those up to 60 years of age 
and after 60 years. It is also worth noting that the level of 
C-reactive protein clearly decreases in patients <60 years of 
age, compared to those> 60 years of age. Although among 
those of >60 years a positive dynamics is maintained at the 
stage after plasmapheresis.
The represented analysis is statistically significant, with 
p value = 0.037. And the improvement of this marker for 
both age groups after performing the isooncotic, isovolemic 
plasmapheresis procedure emphasizes the usefulness of the 
procedure itself in COVID-19 patients in the intensive care 
unit.
Patients over 60 years of age showed a marked improve-
ment in indices compared to patients in the age group up 
to 60 years, in the period after plasmapheresis.  At the same 
time, the study demonstrates the efficiency of achieving iso-
volemic isooncotic plasmapheresis among patients with dif-
ferent age groups. The analysis has statistical significance, 
with p value = 0.041. The result is all the more clinically sig-
nificant as it correlates with the C-reactive protein indicator, 
and the hemodynamic and respiratory stability of patients 
during and after the plasmapheresis procedure.
Conclusions
Isovolemic, isooncotic plasmapheresis is a procedure 
performed in severe COVID-19 (SARS-CoV-2) patients 
to improve the status of the “cytokine storm”. Moreover, 
performing the procedure in different age groups induced 
an improvement in the satiety of hemoleukogram and 
proinflammatory indices. And the presence of concomitant 
diseases did not influence the effectiveness of the results after 
the realization of isovolemic, isooncotic plasmapheresis.
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